What is the appropriate workup and management for a 14-year-old patient with intermittent hypoglycemia confirmed via Continuous Glucose Monitoring (CGM) and a normal Hemoglobin A1c (HbA1c) level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for a 14-Year-Old with Intermittent Hypoglycemia and Normal HbA1c

This adolescent requires a comprehensive evaluation to identify the underlying cause of hypoglycemia, focusing on obtaining a critical sample during a symptomatic episode to measure plasma glucose, insulin, C-peptide, proinsulin, and beta-hydroxybutyrate, while simultaneously screening for endocrine disorders and considering early autoimmune type 1 diabetes. 1

Confirm True Hypoglycemia

  • Verify that plasma glucose is <70 mg/dL during symptomatic episodes, as this threshold confirms true hypoglycemia rather than CGM artifact or normal glycemic variability 1
  • The CGM data should be correlated with fingerstick or laboratory glucose measurements, as CGM accuracy can vary particularly in the hypoglycemic range (MARD up to 31.9% for glucose <70 mg/dL in some systems) 2
  • Document the timing of hypoglycemic episodes (fasting vs. postprandial) as this guides differential diagnosis 1

Obtain Critical Sample During Hypoglycemia

The most diagnostically valuable step is obtaining blood work during an actual hypoglycemic episode (plasma glucose <70 mg/dL), which should include: 1

  • Plasma glucose (laboratory confirmation, not just CGM or fingerstick)
  • Insulin level
  • C-peptide
  • Proinsulin
  • Beta-hydroxybutyrate (ketones)

This "critical sample" distinguishes between hyperinsulinemic causes (elevated insulin/C-peptide with suppressed ketones) versus counter-regulatory hormone deficiencies (low insulin with elevated ketones) 1

Screen for Endocrine Disorders

Evaluate for hormonal deficiencies that impair glucose counter-regulation: 1

  • Morning cortisol and ACTH to screen for adrenal insufficiency (Addison disease), which is a life-threatening cause of hypoglycemia 1
  • TSH and free T4 to exclude hypothyroidism, which can contribute to hypoglycemia 1
  • IGF-1 level if growth velocity is abnormal or if there are other signs suggesting growth hormone deficiency 1

Evaluate for Early Type 1 Diabetes

Test pancreatic autoantibodies (GAD65, IA-2, ZnT8, insulin autoantibodies) to exclude evolving autoimmune type 1 diabetes, as intermittent hypoglycemia can occur in the early stages before overt hyperglycemia develops 1

  • Early type 1 diabetes can present with reactive or postprandial hypoglycemia due to dysregulated insulin secretion 1
  • A normal HbA1c does not exclude early-stage type 1 diabetes, as HbA1c reflects average glucose over 2-3 months and may miss intermittent patterns 2

Consider Metabolic/Genetic Causes

If hypoglycemia occurs primarily with fasting, obtain an acylcarnitine profile to screen for fatty acid oxidation disorders, which prevent appropriate ketone production during fasting 1

  • Hereditary fructose intolerance should be considered if symptoms correlate with fructose ingestion 1

Immediate Safety Measures

Prescribe a glucagon emergency kit (1 mg dose for patients >25 kg or ≥6 years old) for severe hypoglycemic episodes, to be administered subcutaneously or intramuscularly by caregivers 3

  • Educate the patient and family on recognizing hypoglycemia symptoms and treating with 15-20 grams of fast-acting carbohydrate 1
  • Instruct caregivers to call emergency services immediately after administering glucagon 3

Ongoing Monitoring Strategy

  • Continue CGM use to capture patterns and frequency of hypoglycemia, as this technology helps identify episodes that might otherwise be missed 2, 1
  • Review CGM data for patterns: nocturnal hypoglycemia, exercise-related hypoglycemia, or postprandial reactive hypoglycemia 1
  • Document any triggers such as prolonged fasting, specific foods, or physical activity 1

Critical Pitfall to Avoid

Do not assume this is benign reactive hypoglycemia without completing the diagnostic workup, as serious underlying conditions (adrenal insufficiency, insulinoma, early type 1 diabetes) can present with intermittent hypoglycemia and normal HbA1c 1

  • The normal HbA1c indicates average glucose is not elevated, but does not exclude significant glycemic variability or intermittent hypoglycemia 2, 4
  • HbA1c and CGM-derived metrics can be discordant, particularly in conditions with high glycemic variability 4

References

Guideline

Diagnostic Approach for Non-Diabetic Hypoglycemia in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A View Beyond HbA1c: Role of Continuous Glucose Monitoring.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2019

Related Questions

What is the stepwise management of a patient with diabetes, including Hemoglobin A1c (HbA1c) targets?
Should a 30-year-old woman with a history of hypoglycemic (low blood sugar) seizures and nocturnal (night-time) diaphoresis (excessive sweating) with normal glucose levels on four times daily self-monitoring of blood glucose (SMBG) checks undergo continuous glucose monitoring (CGM) or add an additional check at 3:00 AM?
What is the appropriate management for a 35-year-old male with hyperglycemia and an HbA1c of 8?
What is the best course of action for a female patient with diabetes mellitus type II, hyperlipidemia, hypertension, hypothyroidism, and paroxysmal atrial flutter, who has worsening diabetes control as evidenced by an increased HbA1c from 7.7% to 9.4%, and is currently on Lantus (Insulin Glargine), flecainide, and Synthroid (Levothyroxine), with impaired renal function (eGFR of 70)?
What is the treatment for a patient with a hemoglobin A1c (HbA1c) level of 14?
What is the recommended dosing for Nifedipine (Calcium Channel Blocker) extended release in a patient with hypertension or angina, considering factors such as age, kidney function, and liver function?
What is the normal stomach size for a 1-month-old (one month old) baby?
How to manage a 2-hour history of sudden onset right upper and lower limbs weakness in a patient?
What is the appropriate management for a patient with elevated liver enzymes (hypertransaminasemia), specifically AST of 288 and ALT of 375, who has a history of cholecystectomy (gallbladder removal)?
What is the best opioid for a patient with liver disease or at risk for liver damage?
What are the guidelines for managing type 2 diabetes with Glipizide, including dosing, potential side effects, and interactions with other medications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.